Skip to content

Improving Communication in Older Cancer Patients and Their Caregivers

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02107443
Acronym
COACH
Enrollment
546
Registered
2014-04-08
Start date
2014-10-27
Completion date
2020-09-01
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Solid Neoplasm, Lymphoma

Brief summary

Over 60% of cancers occur in older persons, and the number of older persons with cancer is expected to grow as the population ages. Oncology clinical trials have traditionally excluded older patients with advanced cancer and chronic health conditions. In this context, where data is limited and risk from treatment is high, older patients with advanced cancer and their caregivers must understand how cancer treatment can affect quality of life in light of underlying health status. Better communication about age-related health conditions between oncologists, older patients with advanced cancer, and their caregivers may improve decision-making for cancer treatment and quality of life. A geriatric assessment (GA), a validated set of patient-centered outcomes, has been shown to identify concerns (e.g., function, cognition) important to older persons with cancer and their caregivers. In this cluster randomized clinical trial we examined whether providing a web-generated GA summary with targeted recommendations to older patients with advanced cancer, their caregivers, and their oncologists can improve communication about age-related concerns that could affect efficacy and tolerance of cancer treatment. We also determined whether the intervention improves patient-reported quality of life and patient and caregiver satisfaction.

Detailed description

OBJECTIVES: I. Primary Aim - Direct Communication about Age-related Concerns: To determine if providing GA summary plus GA-driven recommendations to patients, their caregivers, and oncology physicians increases discussions about age-related issues during clinic consultation. \[Patient-Centered Outcomes Research Institute (PCORI) specified\] II. Primary Aim - Patient Satisfaction with Communication about Age-related Concerns: To determine if providing geriatric assessment (GA) summary plus GA-driven recommendations to patients, their caregivers and oncology physicians improves patient satisfaction with communication with the oncology physician regarding age-related concerns. \[National Cancer Institute (NCI) specified\] III. Secondary Aim - To determine whether initially providing patients, their caregivers, and oncology physicians with GA summary plus GA-driven recommendations prior to their treatment influences quality of life of older patients receiving treatment and their caregivers. IV. Secondary Aim - To determine whether providing patients, their caregivers, and oncology physicians with GA summary plus GA-driven recommendations influences caregiver satisfaction with communication about age-related issues. OUTLINE: Patients are randomized to 1 of 2 arms. Arm I: At the first study visit with their oncologist, patients and their caregivers (if participating) complete the GA and receive the GA summary plus GA targeted recommendations which is provided to the oncology team to discuss and implement if they so choose. Arm II: At the first study visit with their oncologist, patients and their caregivers (if participating) complete the GA (no GA summary or recommendations are provided). Patients are followed at 4-6 weeks, 3 months, and 6 months. Survival data will be collected at 1 year after enrollment.

Interventions

BEHAVIORALGeriatric Assessment Summary

Complete summary of results from the Geriatric Assessment

BEHAVIORALGeriatric Assessment Targeted Recommendations

Recommendations are made based on areas patients were impaired in on the Geriatric Assessment. They include referrals, tests, medication review, instructions, and support services. The choice of which recommendation to implement is left to the discretion of the physician. Treatment modifications

BEHAVIORALGeriatric Assessment (GA)

A GA measures the issues important to older patients, including function, psychological status, cognitive abilities, social support, and the impact of medical problems on quality of life.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Patient-Centered Outcomes Research Institute
CollaboratorOTHER
Supriya Mohile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Patients * Male or female 70 years of age or older * Diagnosis of an advanced solid tumor malignancy (advanced cancer) or lymphoma. In most situations, this would be a stage IV cancer. A patient with a diagnosis of stage III cancer or lymphoma is eligible if cure is not possible or anticipated. Clinical staging without pathological confirmation of advanced disease is allowed. * Must be considering or currently receiving any kind of cancer treatment (any line), including but not limited to hormonal treatment, chemotherapy, monoclonal antibody therapy, or targeted therapy. Patients who are considering therapy are eligible even if they ultimately choose not to be on therapy. Patients with a history of any previous cancer treatment, including radiation and/or surgery are eligible. A patient may also be enrolled on a treatment trial and participate in this study, if all other inclusion and

Exclusion criteria

are met. * Have at least one geriatric assessment domain meet the cut-off score for impairment other than polypharmacy. * Have visits planned with the oncology physician for at least 3 months and be willing to come in for study visits. * Able to provide informed consent or, if the oncology physician determines the patient to not have decision-making capacity, a patient-designated health care proxy (per institutional policies) must sign consent by the baseline visit. * Subject has adequate understanding of the English language because not all GA measures have been validated in other languages.

Design outcomes

Primary

MeasureTime frameDescription
Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology Physician, and Caregiver. [Patient-Centered Outcomes Research Institute Specified]BaselineA geriatric assessment (GA), a validated set of patient-centered outcomes, has been shown to identify concerns (e.g., function, cognition) important to older persons with cancer and their caregivers. The geriatric assessment was used to define which age related topics discussed between patients and providers would be coded. We will apply linear mixed model methodology. The total number of conversations will be the response, and the arm will be the fixed effect. Estimation will be performed using Restricted Maximum Likelihood, and the null hypothesis of zero mean difference between arms will be tested using a F test. The specific NCORP practice site differences will be assessed graphically using Best Linear Unbiased Predictors (BLUP) of the mean response for each NCORP.
Patient Satisfaction With Communication About Age-related Concerns: Measured by Health Care Climate Questionnaire (HCCQ). [NCI Specified]Within 1-7 days of the baseline audio-recorded clinic consultationWill apply linear mixed model methodology. The total HCCQ scores will be the response, and the arm will be the fixed effect. HCCQ contains 7 questions, scale: 0-28. The higher the score the more satisfied the patients is with communication with their oncologists about age related concerns. Estimation will be performed using Restricted Maximum Likelihood, and the null hypothesis of zero mean difference between arms will be tested using a F test. The specific NCORP practice site differences will be assessed graphically using Best Linear Unbiased Predictors (BLUP) of the mean response for each NCORP.

Secondary

MeasureTime frameDescription
Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Mean score over 4-6 weeks, 3 months, 6 months assessments following the interventionPatient Health Related Quality of Life (HRQoL) will be assessed with the Functional Assessment of Cancer Therapy-General (FACT-G) measured on a 0-108 scale with higher scores indicating a better outcome. We will apply linear mixed model methodology to compare the between arm differences.
Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.At 4-6 weeks, 3 months and 6 months following the interventionWe will compare the effect of the intervention on caregiver satisfaction (the modified health care climate questionnaire (HCCQ)- age for the caregiver, range 0-20; higher score better outcome). We will apply linear mixed model methodology to compare between arm differences.

Countries

United States

Participant flow

Participants by arm

ArmCount
Arm I (GA Informational Intervention)
Patients and their caregivers (if participating) complete the GA and receive the GA summary and recommendations guided by GA results provided by the oncology team to discuss and implement for each age-related issue at baseline. Informational Intervention: Complete GA summary plus GA-driven recommendations
293
Arm II (Usual Care)
Patients and their caregivers (if participating) complete the GA at baseline.
248
Total541

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath4230
Overall StudyRegistered but Not Eligible01
Overall StudyStudy Protocol Violation31
Overall StudyWithdrawal: Changed MD/Facility13
Overall StudyWithdrawal: Changed Mind20
Overall StudyWithdrawal: Disease Progression42
Overall StudyWithdrawal: Disliked Study Procedures12
Overall StudyWithdrawal: Feeling Overwhelmed21
Overall StudyWithdrawal: Hospitalization/Hospice2828
Overall StudyWithdrawal: Other Medical95
Overall StudyWithdrawal: Personal Issues03
Overall StudyWithdrawal: Too Many Forms31
Overall StudyWithdrawal: Too Time Consuming36

Baseline characteristics

CharacteristicArm I (GA Informational Intervention)Arm II (Usual Care)Total
Age, Continuous76.71 years
STANDARD_DEVIATION 5.19
76.41 years
STANDARD_DEVIATION 5.27
76.57 years
STANDARD_DEVIATION 5.22
Cancer Stage
III
28 Participants19 Participants47 Participants
Cancer Stage
IV
261 Participants219 Participants480 Participants
Cancer Stage
Other
3 Participants10 Participants13 Participants
Cancer Stage
Unknown
1 Participants0 Participants1 Participants
Cancer Type
Breast
31 Participants38 Participants69 Participants
Cancer Type
Gastrointestinal
72 Participants66 Participants138 Participants
Cancer Type
Genitourinary
46 Participants33 Participants79 Participants
Cancer Type
Gynecological
22 Participants12 Participants34 Participants
Cancer Type
Lung
78 Participants62 Participants140 Participants
Cancer Type
Lymphoma
23 Participants18 Participants41 Participants
Cancer Type
Other
20 Participants19 Participants39 Participants
Cancer Type
Unknown
1 Participants0 Participants1 Participants
Education
High School
114 Participants81 Participants195 Participants
Education
Less than High School
36 Participants30 Participants66 Participants
Education
More than High School
142 Participants137 Participants279 Participants
Education
Unknown
1 Participants0 Participants1 Participants
GA Impairments4.50 GA impairments
STANDARD_DEVIATION 1.54
4.45 GA impairments
STANDARD_DEVIATION 1.52
4.48 GA impairments
STANDARD_DEVIATION 1.53
Marital Status
Divorced
35 Participants33 Participants68 Participants
Marital Status
Domestic Partnership
2 Participants6 Participants8 Participants
Marital Status
Married
192 Participants148 Participants340 Participants
Marital Status
Separated
1 Participants7 Participants8 Participants
Marital Status
Single, Never Married
3 Participants4 Participants7 Participants
Marital Status
Unknown
1 Participants0 Participants1 Participants
Marital Status
Widowed
59 Participants50 Participants109 Participants
Number of Practice Sites16 participants14 participants30 participants
Race/Ethnicity, Customized
Race/Ethnicity
African American
19 Participants21 Participants40 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Non-Hispanic White
263 Participants219 Participants482 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
10 Participants8 Participants18 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Unknown
1 Participants0 Participants1 Participants
Region of Enrollment
United States
293 participants248 participants541 participants
Sex/Gender, Customized
Gender
Female
137 Participants127 Participants264 Participants
Sex/Gender, Customized
Gender
Male
155 Participants121 Participants276 Participants
Sex/Gender, Customized
Gender
Unknown
1 Participants0 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
42 / 29630 / 250
other
Total, other adverse events
0 / 2960 / 250
serious
Total, serious adverse events
0 / 2960 / 250

Outcome results

Primary

Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology Physician, and Caregiver. [Patient-Centered Outcomes Research Institute Specified]

A geriatric assessment (GA), a validated set of patient-centered outcomes, has been shown to identify concerns (e.g., function, cognition) important to older persons with cancer and their caregivers. The geriatric assessment was used to define which age related topics discussed between patients and providers would be coded. We will apply linear mixed model methodology. The total number of conversations will be the response, and the arm will be the fixed effect. Estimation will be performed using Restricted Maximum Likelihood, and the null hypothesis of zero mean difference between arms will be tested using a F test. The specific NCORP practice site differences will be assessed graphically using Best Linear Unbiased Predictors (BLUP) of the mean response for each NCORP.

Time frame: Baseline

Population: All baseline patients who were evaluable for this primary aim were included in this analysis.~* Arm I patients excluded because 2 withdrew, 1 expired, 4 no audio captured and 2 primary aim protocol violations.~* Arm II patients excluded (3 withdrew, 1 no audio captured).

ArmMeasureValue (LEAST_SQUARES_MEAN)
Arm I (GA Informational Intervention)Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology Physician, and Caregiver. [Patient-Centered Outcomes Research Institute Specified]8.02 Number of Conversations
Arm II (Usual Care)Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology Physician, and Caregiver. [Patient-Centered Outcomes Research Institute Specified]4.43 Number of Conversations
p-value: <0.0001Mixed Models Analysis
Primary

Patient Satisfaction With Communication About Age-related Concerns: Measured by Health Care Climate Questionnaire (HCCQ). [NCI Specified]

Will apply linear mixed model methodology. The total HCCQ scores will be the response, and the arm will be the fixed effect. HCCQ contains 7 questions, scale: 0-28. The higher the score the more satisfied the patients is with communication with their oncologists about age related concerns. Estimation will be performed using Restricted Maximum Likelihood, and the null hypothesis of zero mean difference between arms will be tested using a F test. The specific NCORP practice site differences will be assessed graphically using Best Linear Unbiased Predictors (BLUP) of the mean response for each NCORP.

Time frame: Within 1-7 days of the baseline audio-recorded clinic consultation

Population: All baseline patients who were evaluable for this primary aim were included in this analysis.~* Arm I patients excluded (2 patients withdrew, 19 patients with no HCCQ).~* Arm II patients excluded (3 patients withdrew, 9 no HCCQ).

ArmMeasureValue (LEAST_SQUARES_MEAN)
Arm I (GA Informational Intervention)Patient Satisfaction With Communication About Age-related Concerns: Measured by Health Care Climate Questionnaire (HCCQ). [NCI Specified]23.34 HCCQ total score
Arm II (Usual Care)Patient Satisfaction With Communication About Age-related Concerns: Measured by Health Care Climate Questionnaire (HCCQ). [NCI Specified]22.25 HCCQ total score
p-value: 0.041Mixed Models Analysis
Secondary

Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.

We will compare the effect of the intervention on caregiver satisfaction (the modified health care climate questionnaire (HCCQ)- age for the caregiver, range 0-20; higher score better outcome). We will apply linear mixed model methodology to compare between arm differences.

Time frame: At 4-6 weeks, 3 months and 6 months following the intervention

Population: The number of caregiver's with an available HCCQ at 4-6 weeks

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.4-6 Weeks16.44 score on a scaleStandard Error 0.29
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.3 months16.47 score on a scaleStandard Error 0.3
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.6 months16.49 score on a scaleStandard Error 0.31
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.4-6 Weeks15.39 score on a scaleStandard Error 0.31
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.3 months15.64 score on a scaleStandard Error 0.32
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Caregiver Satisfaction With Communication About Age-related Issues.6 months15.87 score on a scaleStandard Error 0.34
p-value: 0.0395% CI: [0.12, 1.98]Mixed Models Analysis
p-value: 0.0895% CI: [-0.11, 1.77]Mixed Models Analysis
p-value: 0.295% CI: [-0.36, 1.59]Mixed Models Analysis
Secondary

Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.

Patient Health Related Quality of Life (HRQoL) will be assessed with the Functional Assessment of Cancer Therapy-General (FACT-G) measured on a 0-108 scale with higher scores indicating a better outcome. We will apply linear mixed model methodology to compare the between arm differences.

Time frame: Mean score over 4-6 weeks, 3 months, 6 months assessments following the intervention

Population: Enrolled patients who have completed the FACT-G

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.82.93 units on a scaleStandard Error 0.71
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.83.16 units on a scaleStandard Error 0.76
Secondary

Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.

Caregiver Health Related Quality of Life (burden) will be assessed with the Caregiver Reactions Assessment (CRA- \[Overall scale ranges from 1-5, better or worse outcome depending on subscale- Self Esteem Subscale higher score indicates better outcome, Disrupted Schedule subscale lower score indicates better outcome, Financial problems subscale lower score indicates better outcome, Lack of Social Support subscale lower score indicates better outcome, Health Problems subscale lower score indicates better outcome\]). We will apply linear mixed model methodology to compare between arm differences

Time frame: Mean 4-6 weeks, 3 months, and 6 months after the intervention

Population: The number of caregivers with a CRA

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Disrupted Schedule2.57 units on a scaleStandard Error 0.05
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Lack of Social Support1.87 units on a scaleStandard Error 0.04
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Financial Problems1.97 units on a scaleStandard Error 0.04
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Health Problems1.98 units on a scaleStandard Error 0.03
Arm I (GA Informational Intervention)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Self-Esteem4.41 units on a scaleStandard Error 0.03
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Health Problems2.03 units on a scaleStandard Error 0.04
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Self-Esteem4.38 units on a scaleStandard Error 0.03
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Disrupted Schedule2.58 units on a scaleStandard Error 0.06
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Financial Problems2.04 units on a scaleStandard Error 0.04
Arm II (Usual Care)Geriatric Assessment (GA) Summary and GA Targeted-recommendations Provided to Patients, Caregivers and Oncology Physicians Prior to Their Treatment Influences Quality of Life of Older Patients Receiving Treatment and Their Caregivers.Lack of Social Support1.91 units on a scaleStandard Error 0.04

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026